Oxford, United Kingdom

Simon Phillips


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Simon Phillips: Innovator in Pharmaceutical Compounds

Introduction

Simon Phillips is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating proliferative disorders such as cancer. With a total of 2 patents to his name, Phillips has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Phillips' latest patents focus on compounds of Formula I, which are designed to inhibit RAS-effector protein-protein interactions. These compounds are not only relevant for pharmaceutical compositions but also hold promise for treating various diseases where such interactions are implicated. His work emphasizes the importance of these compounds in the fight against cancer and other proliferative disorders.

Career Highlights

Throughout his career, Simon Phillips has been associated with prestigious institutions such as the Institute of Cancer Research: Royal Cancer Hospital and Oxford University Innovation Ltd. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical sector.

Collaborations

Phillips has collaborated with esteemed colleagues, including Terrence Rabbitts and Camilo Quevedo. These partnerships have further enriched his research and have played a crucial role in the advancement of his innovative projects.

Conclusion

In summary, Simon Phillips is a dedicated inventor whose work in pharmaceutical compounds has the potential to make a significant impact on the treatment of cancer and other diseases. His innovative approach and collaborations highlight the importance of research in developing effective medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…